Source:http://linkedlifedata.com/resource/pubmed/id/10418209
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-8-5
|
pubmed:abstractText |
Isolated systolic hypertension (ISH) is a risk factor for cardiovascular disease. Extended-release felodipine (felodipine ER) has been shown to be effective in the treatment of ISH in Caucasians. However, its pharmacological properties are different from another calcium blocker, diltiazem. Also, the effectiveness, tolerability, and adverse reactions of these two antihypertensive agents for ISH have not been thoroughly assessed in Chinese.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:author | |
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
44-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10418209-Adult,
pubmed-meshheading:10418209-Aged,
pubmed-meshheading:10418209-Calcium Channel Blockers,
pubmed-meshheading:10418209-Diltiazem,
pubmed-meshheading:10418209-Felodipine,
pubmed-meshheading:10418209-Female,
pubmed-meshheading:10418209-Humans,
pubmed-meshheading:10418209-Hypertension,
pubmed-meshheading:10418209-Male,
pubmed-meshheading:10418209-Middle Aged
|
pubmed:year |
1999
|
pubmed:articleTitle |
Comparison of clinical efficacy and adverse effects between extended-release felodipine and slow-release diltiazem in patients with isolated systolic hypertension.
|
pubmed:affiliation |
Department of Internal Medicine, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taouan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|